XML 34 R19.htm IDEA: XBRL DOCUMENT
v3.22.4

Income Taxes | 12 Months Ended
--- | ---
Jan. 31, 2023
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes The domestic and international components of the Company's loss from operations before income taxes are as follows:
| Fiscal year ended January 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Domestic | $ | (66,194) |  |  | $ | (95,062) |  |  | $ | (69,953) |
International | 2,336 |  |  | 3,080 |  |  | (24,642) |
Loss from operations before income taxes | $ | (63,858) |  |  | $ | (91,982) |  |  | $ | (94,595) |
The Company's (provision for) benefit from income taxes is comprised of the following:
| Fiscal year ended January 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Current: |  |  |  |  |
Federal | $ | (42) |  |  | $ | (9) |  |  | $ | 313 |
State | (491) |  |  | (184) |  |  | (198) |
International | (732) |  |  | (884) |  |  | (1,070) |
Total current | (1,265) |  |  | (1,077) |  |  | (955) |
Deferred: |  |  |  |  |
Federal | (4) |  |  | (4) |  |  | (28) |
State | (3) |  |  | (4) |  |  | (31) |
International | (808) |  |  | (192) |  |  | 917 |
Total deferred | (815) |  |  | (200) |  |  | 858 |
Total provision for income taxes | $ | (2,080) |  |  | $ | (1,277) |  |  | $ | (97) |
The Company’s current tax provision is primarily attributable to profitable jurisdictions outside of the United States (U.S.) and U.S. state income taxes due to mandatory capitalization of research and experimental expenditures. In the fiscal year ended January 31, 2021, the Company released a portion of its valuation allowance against certain foreign deferred tax assets resulting in an income tax benefit of $0.7 million, and recorded a U.S. tax benefit of $0.2 million due to the expiration of certain statutes of limitations of unrecognized tax benefits. The Company reconciled its income taxes at the federal statutory income tax rate to the provision for income taxes included within its consolidated statements of operations and comprehensive loss. The Company elected to account for its Global Intangible Low-Taxed Income as an expense in the period it is incurred. The reconciliation is as follows:
| Fiscal year ended January 31,
(in thousands) | 2023 |  | 2022 |  | 2021
U.S. federal tax (provision) benefit at statutory rate | $ | 13,410 |  |  | $ | 19,316 |  |  | $ | 19,865 |
State taxes, net of federal benefit | 479 |  |  | 4,344 |  |  | 5,000 |
Foreign tax rate differential | (42) |  |  | (132) |  |  | (2,130) |
Non-deductible expenses | (1,492) |  |  | (1,244) |  |  | (329) |
Change in valuation allowance | (4,399) |  |  | (22,027) |  |  | (23,900) |
Rate change | 62 |  |  | (66) |  |  | 131 |
Stock-based compensation | (2,500) |  |  | (1,489) |  |  | (1,929) |
Net excess tax (shortfalls) benefits from stock-based compensation | (6,498) |  |  | (990) |  |  | 3,444 |
Return to provision adjustment | 235 |  |  | 1,718 |  |  | 16 |
Global intangible low-taxed income | (1,096) |  |  | — |  |  | (6,129) |
Intra-entity asset transfer | — |  |  | — |  |  | 3,944 |
Other, net | (239) |  |  | (707) |  |  | 1,920 |
Total provision for income taxes | $ | (2,080) |  |  | $ | (1,277) |  |  | $ | (97) |
Deferred Income Taxes Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating loss carryforwards. The components of the Company's deferred income taxes are as follows:
| As of January 31,
(in thousands) | 2023 |  | 2022
Deferred tax assets: |  |  |
Net operating loss carryforwards | $ | 126,654 |  |  | $ | 136,226 |
Stock-based compensation | 5,075 |  |  | 7,271 |
Allowance for doubtful accounts | 220 |  |  | 523 |
Operating lease liability | 28,960 |  |  | 32,156 |
Accrued expenses | 2,893 |  |  | 2,372 |
Unearned revenue | 110 |  |  | 61 |
Capitalized research & experimental expenditures | 12,781 |  |  | — |
Intangible assets | 10,943 |  |  | 10,625 |
Other | 169 |  |  | 339 |
Total deferred tax assets | 187,805 |  |  | 189,573 |
Less: valuation allowance | (155,604) |  |  | (151,205) |
Deferred tax assets, net of valuation allowance | 32,201 |  |  | 38,368 |
Deferred tax liabilities: |  |  |
Property and equipment | (1,411) |  |  | (2,440) |
Costs to obtain revenue contracts | (9,179) |  |  | (11,041) |
Operating lease right-of-use assets | (20,795) |  |  | (23,259) |
Other | (877) |  |  | (874) |
Total deferred tax liabilities | (32,262) |  |  | (37,614) |
Net deferred tax asset (liability) | $ | (61) |  |  | $ | 754 |
As of January 31, 2023, for federal income tax purposes, the Company had $460.4 million of gross U.S. federal net operating loss carryforwards, with pre-2018 net operating losses expiring starting in fiscal 2033 and others indefinitely carried forward. As of January 31, 2023, for state income tax purposes, the Company had $22.6 million of post-apportioned, tax-effected net operating loss carryforwards, which expire in fiscal 2024 through fiscal 2041. As of January 31, 2023, the Company had $7.3 million of tax-effected foreign net operating loss carryforwards which expires starting in fiscal 2026. Utilization of the Company’s net operating loss carryforwards in the future will be dependent upon its ability to generate taxable income and could be limited due to ownership changes, as defined under the provisions of Section 382 of the Code and similar state provisions. Utilization of the Company’s foreign net operating loss carryforwards in the future will be dependent upon the local tax law and regulation. The Company regularly evaluates the realizability of its deferred tax assets and establishes a valuation allowance if it is more likely than not that some or all the deferred tax assets will not be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, loss carryback and tax-planning strategies. Generally, more weight is given to objectively verifiable evidence, such as the cumulative loss in recent years, as a significant piece of negative evidence to overcome. During the fiscal year ended January 31, 2023, the valuation allowance had a net increase of $4.4 million from approximately $151.2 million to $155.6 million, primarily due to a decrease in U.S. deferred tax liabilities. The Company also recorded valuation allowances in certain foreign jurisdictions due to the cumulative book loss in the consolidated group. During the fiscal year ended January 31, 2022, the valuation allowance increased by $22.0 million from approximately $129.2 million to $151.2 million, primarily due to the impact of the net operating loss carryforwards established in the current period net with other changes in U.S. deferred tax assets. The Company will continue to assess the realizability of the deferred tax assets in each applicable jurisdiction going forward. Other Considerations U.S. income tax has not been recognized on the excess of the amount for financial reporting over the tax basis of certain investments in foreign subsidiaries that is indefinitely reinvested. The Company may be subject to state income taxes and withholding taxes upon distribution of non-U.S. earnings in the form of dividends. The Company does not believe these taxes are material. A reconciliation of the beginning and ending balance of total unrecognized tax benefits for the fiscal years ended January 31, 2023, 2022, and 2021 is as follows:
| Fiscal year ended January 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Beginning of period | $ | 288 |  |  | $ | 267 |  |  | $ | 493 |
Tax positions taken in prior period |  |  |  |  |
Gross increases | — |  |  | — |  |  | — |
Gross decreases | (272) |  |  | — |  |  | (13) |
Tax positions taken in current period |  |  |  |  |
Gross increases | — |  |  | 20 |  |  | — |
Lapse of statute of limitations | — |  |  | — |  |  | (233) |
Currency translation effect | (16) |  |  | 1 |  |  | 20 |
End of period | $ | — |  |  | $ | 288 |  |  | $ | 267 |
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the (provision for) benefit from income taxes and recognized insignificant interest and penalties in each of the fiscal years ended January 31, 2023, 2022, and 2021. As of January 31, 2023, 2022 and 2021, accrued unrecognized tax benefits were $— million, $0.3 million and $0.3 million, respectively, and if recognized would reduce the (provision for) benefit from income taxes, and the Company's effective tax rate. The Company is subject to income tax examinations in the United States and various state and foreign jurisdictions. The Company’s most significant operations are in the United States and the earliest open tax year subject to potential examination in the United States is 2008.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 14 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 270 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -URI https://asc.fasb.org/topic&trid=2144680 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration